Get the Stockscreener App
103.00
9.03%
8.53
After Hours:
101.51
-1.49
-1.45%
Lantheus Holdings Inc stock is traded at $103.00, with a volume of 2.01M.
It is up +9.03% in the last 24 hours and up +24.28% over the past month.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
See More
Previous Close:
$94.47
Open:
$94.4
24h Volume:
2.01M
Relative Volume:
2.03
Market Cap:
$6.71B
Revenue:
$1.54B
Net Income/Loss:
$233.56M
P/E Ratio:
30.59
EPS:
3.3669
Net Cash Flow:
$348.64M
1W Performance:
+9.68%
1M Performance:
+24.28%
6M Performance:
+84.52%
1Y Performance:
+37.79%
1-Day Range:
$93.73
$103.89
1-Week Range:
$91.65
$103.89
52-Week Range:
$47.25
$103.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
103.00 | 6.15B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-12-25 | Upgrade | Truist | Hold → Buy |
| Oct-08-25 | Downgrade | Goldman | Buy → Neutral |
| Aug-12-25 | Downgrade | Truist | Buy → Hold |
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Avoiding Lag: Real-Time Signals in (LNTH) Movement - Stock Traders Daily
Lantheus Holdings gains after report it's evaluating a sale after offer - MSN
Lantheus (LNTH) Considers Sale Following Curium Acquisition Prop - GuruFocus
Lantheus Holdings stock hits 52-week high at 101.01 USD By Investing.com - Investing.com India
Lantheus Holdings (LNTH) Evaluates $7 Billion Sale After Curium Offer - GuruFocus
Lantheus (LNTH) Considers Sale Following $7 Billion Takeover Pro - GuruFocus
Lantheus weighs potential $7 billion sale after Curium’s offer, Bloomberg News reports - WSAU
Lantheus Holdings shares jump on report co is exploring a sale By Investing.com - Investing.com South Africa
Is Lantheus Holdings Inc (LNTH) Overvalued After 9.1% Rally? GF - GuruFocus
Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports - Reuters
Lantheus Holdings shares jump on report co is exploring a sale - Investing.com India
Lantheus Explores Potential $7 Billion Sale Following Offer From Curium - Bloomberg.com
Lantheus weighs potential $7 billion sale, Bloomberg News reports - marketscreener.com
Lantheus weighs potential $7 billion sale following offer from CuriumBloomberg news - marketscreener.com
Lantheus Holdings stock hits 52-week high at 101.01 USD - Investing.com
Lantheus Weighs Potential $7 Billion Sale Following Offer From Curium - Bloomberg.com
How The Story On Lantheus Holdings (LNTH) Is Shifting With PYLARIFY And Pipeline Expectations - Yahoo Finance
Earnings Preview: Lantheus to Report Financial Results Pre-market on May 07 - Moomoo
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting - The Manila Times
New scans for prostate cancer and blood clots head to LA meeting - Stock Titan
A Look at Lantheus Holdings Inc (LNTH) After 3.5% Gain -- GF Val - GuruFocus
Should Lantheus’ Q1 Beat And ASCO 2026 Pipeline Update Require Action From Lantheus Holdings (LNTH) Investors? - simplywall.st
These analysts raise their forecasts on Lantheus after upbeat Q1 results - MSN
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology ... - Caledonian Record
Cancer trial data on LNTH-2403 and prostate imaging headed to ASCO 2026 - Stock Titan
Overheating Stocks: iHeartMedia, Array, Lantheus Under ScrutinyNews and Statistics - IndexBox
Director James H. Thrall receives 4,137 Lantheus (LNTH) shares in grant - Stock Titan
Lantheus (LNTH) director Julie McHugh receives 4,137-share stock grant - Stock Titan
Lantheus (LNTH) director receives 4,137-share stock grant in Form 4 filing - Stock Titan
Lantheus (LNTH) director Maeusli Heinz Christoph receives 4,137-share stock grant - Stock Titan
Director at Lantheus (NASDAQ: LNTH) receives 4,137-share stock grant - Stock Titan
Lantheus (NASDAQ: LNTH) director Gary J. Pruden awarded 4,137 shares - Stock Titan
Lantheus Holdings (LNTH) grants director 4,137 common shares - Stock Titan
Lantheus (LNTH) director granted 4,137 common shares - Stock Titan
Lantheus Holdings (LNTH) director granted 4,137 common shares in Form 4 filing - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy With 10.83% Upside Potential - DirectorsTalk Interviews
Lantheus Holdings (LNTH) price target increased by 10.39% to 103.33 - MSN
Lantheus Holdings Inc stock (US5156731020): analysts see upside after recent volatility - AD HOC NEWS
Lantheus Holdings Inc stock (US5156731020): Q1 2026 earnings beat and renewed interest in radiopharm - AD HOC NEWS
Lantheus Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LNTH) 2026-05-15 - Seeking Alpha
Janus Henderson (LNTH) holds 4.77M shares of Lantheus, 7.4% stake disclosed - Stock Titan
We Think You Should Be Aware Of Some Concerning Factors In Lantheus Holdings' (NASDAQ:LNTH) Earnings - Sahm
Lantheus Holdings stock (US5156731020): Q1 earnings beat sparks 44% YTD rally - AD HOC NEWS
Lantheus reiterates $1.4B-$1.45B 2026 revenue outlook while targeting PYLARIFY TRUVU transition in Q4 - MSN
Discipline and Rules-Based Execution in LNTH Response - Stock Traders Daily
Earnings call transcript: Lantheus Holdings beats Q1 2026 expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Lantheus Holdings beats Q1 2026 expectations - Investing.com
Montagut Appointed SVP of Corporate Development at Lantheus | Business | Oct 2018 - Photonics Spectra
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):